Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
Novo Nordisk A/S
Celgene
Gilead Sciences
Chang Gung Memorial Hospital
INSYS Therapeutics Inc